The Diagnosis and Prenatal Management of Non‐RHD Alloimmunizations
Prenatal Diagnosis · 05.08.2026
DOI: 10.1002/pd.70231 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Prenatal Diagnosis, online erschienen am 05.08.2026. Verfasst von Mar Bennasar und 1 weiteren Autor:innen. Beteiligte Einrichtung: BCNatal. Barcelona Center for Maternal-Fetal and Neonatal Medicine, Institut Clínic de Ginecologia, Obstetricia i Neonatologia, Hospital Clínic de Ba…. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Red blood cell (RBC) alloimmunization remains a relevant cause of hemolytic disease of the fetus and newborn (HDFN). Although RhD immunization has significantly decreased since the implementation of systematic prophylaxis, it is still the main cause of alloimmunization in pregnancy. Clinically significant non‐RhD alloantibodies, particularly those of the Rh (c, C, E), Kell, Kidd, Duffy, and MNS systems, are associated with variable risk of fetal anemia and account for an increasing proportion of alloimmunized pregnancies requiring specialized prenatal care. Most diagnostic algorithms and management protocols are based on evidence derived from RhD alloimmunization. Although these frameworks are often extrapolated to other alloantibodies, important differences exist regarding antibody titration and critical thresholds, the diagnostic accuracy of non‐invasive fetal antigen genotyping, and the risk and timing of fetal and neonatal interventions. These differences underscore the need for antibody‐specific considerations in the prenatal diagnosis and management of non‐RhD alloimmunization. Though advances in non‐invasive diagnostic techniques have improved risk stratification and optimized prenatal management, individualized care pathways in alloimmunized pregnancies are needed. This review will focus on the current strategies for prenatal diagnosis and risk assessment in pregnancies complicated by non‐RhD red cell alloimmunization.
Autor:innen und Institutionen
- BCNatal. Barcelona Center for Maternal-Fetal and Neonatal Medicine, Institut Clínic de Ginecologia, Obstetricia i Neonatologia, Hospital Clínic de Barcelona, Barcelona, Catalonia, Spain.
- Department of Medical-surgical Specialties, Medical Sciences School, Universitat de Barcelona, Barcelona, Catalonia, Spain.
ORCID-Profile: Mar Bennasar, Antoni Borrell
Zitieren
APA
Bennasar, M., & Borrell, A. (2026). The Diagnosis and Prenatal Management of Non‐RHD Alloimmunizations. Prenatal Diagnosis. https://doi.org/10.1002/pd.70231
Vancouver
Bennasar M, Borrell A. The Diagnosis and Prenatal Management of Non‐RHD Alloimmunizations. Prenatal Diagnosis. 2026. doi:10.1002/pd.70231
BibTeX
@article{Bennasar2026,
author = {Bennasar, Mar and Borrell, Antoni},
title = {The Diagnosis and Prenatal Management of Non‐RHD Alloimmunizations},
journal = {Prenatal Diagnosis},
year = {2026},
doi = {10.1002/pd.70231}
}
EUVIMED